Curing Type 1 diabetes has been a primary goal for stem-cell research since the mid 1990s, but experts say scientists are still years away from success. In this article from the Los Angeles Times, a journalist talks to researchers about the simplicity of the concept, and why getting cells to become insulin-producers is so difficult in reality.
President Obama today, March 9, 2009, increased hope throughout the medical community for future treatments of diabetes and many other... Read more »
This week, the World Stem Cell Summit was in Baltimore and on Monday I was invited to check out the poster forum and to hear the opening... Read more »
Last week, I got a last minute email from JDRF Capitol Chapter about tickets to a documentary on embryonic stem cell research called The... Read more »
This past week, NIH approved the use of human embryonic stem cells for research being funded by federal money, a move that overturns 8... Read more »
ABC News recently aired an item that discussed the tuberculosis (TB) risk in children and adolescents that may have caused alarm for... Read more »
A new study found that 20 out of 23 Type 1 diabetics who were given stem cell transplants did not need to take insulin for two to four years. The... Read more »
Source: ADAM Encyclopedia
A stem cell is a generic cell that can make exact copies of itself indefinitely. A stem cell has the ability to produce specialized cells for various... Read more »